Calculator and clinical decision support for the AAP 2022 guidelines for the management of hyperbilirubinemia in newborns 35 or more weeks of gestation.
| GA at birth | 40 completed weeks | |
| Postnatal age | 48 hours | |
| Bilirubin | 10 mg/dL | |
| Phototherapy threshold | Exchange threshold | |
|---|---|---|
| No neurotoxicity risk factors | 17 mg/dL | 24 mg/dL |
| ANY neurotoxicity risk factors | 14 mg/dL | 20.1 mg/dL |
| Phototherapy threshold minus bilirubin measurement | Discharge recommendations | |
| 0.1 - 1.9 mg/dL | Age <24 hours | Delay discharge, consider phototherapy, measure TSB in 4 to 8 hours |
| Age ≥24 hours | Measure TSB in 4 to 24 hours. Options:
| |
| 2.0 - 3.4 mg/dL | (regardless of age) | TSB or TcB in 4 to 24 hours |
| 3.5 - 5.4 mg/dL | (regardless of age) | TSB or TcB in 1– 2 days |
| 5.5 - 6.9 mg/dL | Discharging <72 hours | Follow-up within 2 days; TcB or TSB according to clinical judgment |
| Discharging ≥72 hours | Clinical judgment | |
| ≥7.0 mg/dL | Discharging <72 hours | Follow-up within 3 days; TcB or TSB according to clinical judgment |
| Discharging ≥72 hours | Clinical judgment | |
(Complete discharge follow-up table may be helpful to provide comparative context)
| Optional age calculator | |
| Date of birth | |
| Date of measurement | |
Script by Joseph Chou, 2023-08-15
DISCLAIMER
The User acknowledges and agrees that this tool will be used only as a reference aid, and that the information contained in the product is not intended to be (nor should it be used as) a substitute for the exercise of professional judgement.
In view of the possibility of human error or changes in medical science, the User should confirm the information in the product through independent sources. This product is provided without warranties of any kind, express or implied, and the author disclaims any liability, loss, or damage caused by it or its content.
By continuing to use this product, you have indicated your acceptance of these terms.
Neurotoxicity Risk Factors
Based on